U.S. Software Stock News

In recent coverage, Allient (NASDAQ: ALNT), a maker of precision and specialty-controlled motion components, has been reported as experiencing a 1.7% annual sales decline over the past two years, alongside falling earnings per share and low returns on capital, raising fresh questions about how effectively management is deploying resources. These trends suggest that the company’s vertically integrated model and capital allocation choices may not yet be translating into the operational...

Cirrus Logic annual meeting and record revenue set the stage Cirrus Logic (CRUS) drew fresh investor attention after shareholders approved all proposals at the 2026 annual meeting and the company reported record fiscal 2026 revenue of about US$2b. See our latest analysis for Cirrus Logic. Despite record revenue and the annual meeting approvals, Cirrus Logic’s share price has eased in recent months, with the 30 day share price return down 11.66% and the 90 day share price return down 21.24%,...

Fortinet (FTNT) has drawn fresh attention after reporting second quarter 2026 results that exceeded its own guidance, raising full year revenue targets and tying the outlook to new AI focused security products. See our latest analysis for Fortinet. The share price reaction has been strong, with Fortinet stock up 4.99% on a 1 day basis and showing a 90 day share price return of 87.68% alongside a 1 year total shareholder return of 66.34%. This points to building momentum off the back of raised...

Recently, Argan, Inc. saw heightened options activity, with the Dec. 18, 2026 $240 call emerging as one of the most volatile contracts, while analysts assigned the company a Zacks Rank #1 (Strong Buy) and raised earnings estimates for the current quarter. This combination of active options trading and upgraded analyst expectations signals elevated investor focus on Argan’s near‑term operating outlook and earnings power. Next, we’ll examine how this spike in options activity and analyst...

Federated Hermes stock barely budged on the earnings news, ticking up less than 1%, even though the quarter delivered record assets and a solid profit print. Investors who came in expecting just another money market story instead saw basic earnings per share at about US$1.45 and total revenue around US$503 million, both supported by higher assets under management. The real headline is simple. This was a profitability and scale quarter, not a dramatic rerating one. The share price reaction...

Caledonia Mining stock has delivered an 86.6% gain over the past five years, yet the recent share price slide this year raises the question of whether the current level still looks cheap based on the broader valuation checks. The 86.6% return over five years points to a stock that has already rewarded long term holders, so new investors need to consider how much value is still left on the table. Fresh drilling success at the Blanket Mine, including the new K Pits target and planned heap...

T. Rowe Price Group stock has delivered a decline of about 35.0% over the past 5 years, yet current valuation checks and the intrinsic value estimate from the Excess Returns model both indicate the shares may be trading at a discount to what the business could be worth. The roughly 35.0% share price decline over 5 years means long term holders have seen meaningful capital losses despite more recent gains. Investor focus on earnings prospects for smaller companies, highlighted by interest in...

UMH Properties stock sits at the center of a valuation split, with the intrinsic value estimate from a Discounted Cash Flow (DCF) model pointing to a sizeable potential discount, while traditional market multiples suggest the shares already trade at a premium. The stock has also delivered mixed long term returns, which adds another layer to the debate about what investors are really paying for. Over the past 5 years the share price is down about 20%, which means long term holders have not...

LeMaitre Vascular (LMAT) has drawn investor attention after recent share price moves, with the stock closing at $101.32 on 29 July 2026. The company operates in the medical devices segment focused on vascular surgery. See our latest analysis for LeMaitre Vascular. Recent trading reflects that momentum in LeMaitre Vascular has cooled slightly in the very short term, with a 1 day share price return that declined 0.85%, following a strong year to date share price return of 26.38% and a 5 year...

Modine Manufacturing Company recently reported past first-quarter fiscal 2027 results, with sales rising to US$874.1 million and net income to US$73.9 million, alongside diluted earnings per share from continuing operations of US$1.37. At the same time, management issued new guidance calling for fiscal 2027 net sales to increase by 20% to 35%, underlining confidence in demand for its data center and advanced thermal solutions businesses. Now we’ll examine how Modine’s stronger quarterly...

Life Time Group Holdings walked into this earnings print with its stock already on a strong run, up roughly 69% over the past three months and another 2% on the day around the release. For a fitness and wellness operator often framed as a long term growth story, the headline this quarter is straightforward. Revenue reached about US$866m and net income came in just over US$100m, while adjusted EBITDA margin moved into the high 20s. The market reaction so far suggests investors are treating...

Coinbase Global is waking up to a harsh verdict. The stock dropped about 11% to roughly US$146 after investors reacted to fresh quarterly numbers that showed another loss and softer revenue. The short term message is blunt. Crypto volumes and fee income are not doing enough right now to offset the cost base. The long term question is very different. Coinbase is still being valued at more than 6x sales while trailing twelve month earnings sit in the red. The key takeaway from this earnings...

In late July 2026, Novo Nordisk reported that its late-stage ZEUS trial for the anti-inflammatory drug ziltivekimab did not meet its primary goal, prompting investors to reassess the broader inflammation-focused drug landscape. Because Monte Rosa Therapeutics works on inflammation-related biology, this setback for a large pharmaceutical peer heightened scrutiny of its own scientific approach and pipeline risk profile. We will now examine how this high-profile anti-inflammatory trial...

Eversource Energy stock has delivered a 22.2% return over the past three years, yet its current valuation sends mixed signals, with the Dividend Discount Model (DDM) implying the shares trade at a premium while earnings based multiples point to better value. The 22.2% three year return suggests Eversource Energy has already rewarded patient shareholders, which raises the bar for any new upside from here. The refocus on regulated electric and natural gas delivery after the Aquarion Water sale...

Curtiss-Wright (CW) heads into its June 2026 quarter earnings with expectations for growth in earnings per share, after analysts raised their consensus forecasts over the past month. See our latest analysis for Curtiss-Wright. The recent pullback, with a 7 day share price return of 3.49% and a 30 day share price return of 4.46%, contrasts with Curtiss-Wright’s stronger year to date share price return of 26.49% and a 5 year total shareholder return above 5x. This suggests longer term momentum...

The GEO Group, Inc. recently announced a five-year support services contract with U.S. Immigration and Customs Enforcement for exclusive use of its 1,320-bed Rivers Facility in Winton, North Carolina, which is expected to generate about US$80,000,000 in annual revenue in its first full year. The agreement deepens GEO’s role in federal immigration processing by bundling security, maintenance, food service, recreation, medical care, and access to legal counsel into a single, long-term...

AI linked cyber attacks from OpenAI and Anthropic have pushed cybersecurity risk from background concern to front page story. Investors are now weighing where the real winners and weak spots might sit as regulators talk tougher rules and legal liability for AI driven breaches. This screener focuses on larger cybersecurity companies whose tools help protect networks, endpoints and cloud systems. The article will walk through 3 stocks that appear positively exposed to this surge in attention on...

Capital One Financial has delivered a 92.4% share price gain over the past three years, yet its current checks still point to a stock that screens as undervalued rather than fully priced in. Both the Excess Returns intrinsic value estimate and market multiples lean in the same direction, which puts more focus on whether that apparent discount is justified by the risks now in view. Over the past three years the stock is up 92.4%. This means anyone looking at Capital One Financial today is...

General Electric (GE) is back in focus after Philippine Airlines agreed to use its GEnx 1B engines on a future Boeing 787 10 fleet, drawing attention to the company’s commercial aerospace franchise. See our latest analysis for General Electric. That Philippine Airlines deal arrives as General Electric shares hold at US$360.07, with a 90 day share price return of 25.67% and a 1 year total shareholder return of 34.34%. This points to momentum that has built over a multi year period, despite a...

In July 2026, National Bank Holdings Corporation reported second-quarter and first-half 2026 results, with net interest income rising to US$109.29 million for the quarter and US$218.09 million for the half-year, while net income and earnings per share from continuing operations declined compared with the prior year periods. Alongside these mixed earnings, the company also completed a tranche of its January 2026 share repurchase program, buying back 664,579 shares for US$27.21 million in...

Regeneron Pharmaceuticals stock jumped about 3% to around US$763 after its latest report, a clear sign traders liked what they saw in the headline numbers. The bigger story sits in the profit engine behind that move. Quarterly basic earnings per share came in at US$12.62 on revenue of US$4.29b, while trailing net margin stands at 27.9%, compared with 31.4% a year earlier. In the short term, the market is cheering the earnings print. Over a longer horizon, investors now have to weigh that...

In July 2026, Red Cat Holdings, Inc. disclosed that its Board had decided to terminate Chief Revenue Officer Geoffrey Hitchcock for cause, prompting Hitchcock to file a civil complaint alleging retaliatory termination, breach of contract, and related claims, while the company denies wrongdoing and plans a vigorous legal defense without severance or accelerated equity for him. On the upside for operations, Red Cat’s Teal Drones subsidiary secured a US$2.49 million firm-fixed-price contract...

STERIS plc has increased its quarterly interim dividend to US$0.69 per share, up US$0.06, marking its 21st consecutive year of dividend growth, with the payment made on 25 September 2026 to shareholders of record on 4 September 2026. This extended streak of rising dividends underlines management’s consistent commitment to shareholder returns and may matter for investors focused on income reliability. We’ll now examine how this higher quarterly dividend and long track record of dividend...

Cigna Group stock was essentially flat over the past month going into the earnings release, then slipped almost 3% to about US$279 as investors digested the latest numbers. The market is reacting to headlines, but the earnings story centers on profit power. Adjusted EPS guidance has been lifted to at least US$30.45 for 2026, while quarterly adjusted EPS came in at US$7.78 on US$71.7 billion of revenue. That combination of a sliding share price and firmer earnings guidance sets up a clear...